AZN has been in the news 364% more than usual
Jan 14, 2025, 5:32 PM
14.90%
What does AZN do
It seems there was an error, as the content you provided is marked as "undefined." Please provide specific content for summarization.
AZN has been in the news recently: AstraZeneca and Daiichi Sankyo's drug datopotamab deruxtecan has received Priority Review from the FDA for treating advanced EGFR-mutated non-small cell lung cancer, with a decision expected by July 12, 2025. Additionally, Synthego has signed a licensing agreement with AstraZeneca to manufacture and distribute the eSpOT-ON CRISPR enzyme for gene editing research.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.